InsidersTradesSigma
Follow the ATOSSA GENETICS INC share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €24.2m. The latest transaction was filed on 21 January 2016 (Acquisition). Among the most active insiders: QUAY STEVEN C. The full history is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Atossa Genetics Inc is a biotechnology company focused on developing treatments for breast diseases. It is listed on NASDAQ under the ticker symbol ATOS.